Richard Dobbs

Why I’m considering cancelling my second Covid jab

issue 22 May 2021

I am considering cancelling my second Covid-19 vaccination. I received my first jab in March, and at the time I happily booked the date for the second one in June, confident that by then we would be continuing to see a fall in infections.

But last week the story changed. The B.1.617.2 variant, first identified in India, could, according to Sage minutes, be 50 per cent more transmissible than the variant identified in Kent. Early numbers suggest we could be at the start of an exponential growth in infections. The lesson of the past year is that if you wait to act until you’re certain of the data, you’re too late in changing your plans. Here, therefore, are four areas to consider now.

In the race between vaccines and the virus, we are still constrained by supply, so wouldn’t it be better if people who, like me, have already had Covid cancelled our second jabs and waited for the planned autumn booster, thereby allowing others to have their first shot instead? While when infections were very low it made sense not to use the AstraZeneca shot for the under-thirties, this decision might need revisiting if infections rise. Should we tighten up the restrictions for those travelling from amber countries such as France where 10 per cent of infections in Paris are from the more vaccine-busting South African variant? And would face masks in schools now make sense? Let’s illustrate how the Indian variant might have shifted the balance by looking at the first of these.

‘I’m getting them in before the next lockdown.’

The science in our understanding of vaccines is evolving, but recent US research has shown that those of us who suffered from Covid last year are at least as strongly protected after one jab as those who had not suffered from Covid are after two vaccine shots.

GIF Image

You might disagree with half of it, but you’ll enjoy reading all of it

TRY 3 MONTHS FOR $5
Our magazine articles are for subscribers only. Start your 3-month trial today for just $5 and subscribe to more than one view

Comments

Join the debate for just £1 a month

Be part of the conversation with other Spectator readers by getting your first three months for £3.

Already a subscriber? Log in